Novavax Ab

Calculating rank

USPTO Granted Patents = 7

EPO Patents = 1

Trademarks = 3

Forward Citations = 27

Loading Chart...

8 inventors (with patents filed for the assignee):

Bror Morein (7 out of 25 patents)

Karin Lövgren Bengtsson (3 out of 5 patents)

Karin Lovgren Bengtsson (3 out of 6 patents)

4. Albertus D M E Osterhaus (2 out of 3 patents)

5. Karin Lovgren-Bengtsson (1 out of 2 patents)

6. Kefei Hu (1 out of 4 patents)

7. Jill Ekstrom (1 out of 5 patents)

8. Katarina Ranlund (1 out of 4 patents)

9. Karin Bengtsson LÖVGREN (0 patent)

10. ADME Osterhaus (0 patent)

7 patents: Sort by Forward Citations

1. 10813994 - Composition comprising iscom particles and live micro-organisms (2020-10-27),

2. 10736958 - Influenza vaccine (2020-08-11),

3. 10729764 - ISCOM preparation and use thereof (2020-08-04),

4. 10485863 - Influenza vaccine (2019-11-26),

5. 9901634 - Compositions comprising iscom particles and live micro-organisms (2018-02-27),

6. 9205147 - Composition comprising iscom particles and live micro-organisms (2015-12-08),

7. 8821881 - Quil A fraction with low toxicity and use thereof (2014-09-02),

Company Overview

Novavax is a biotechnology company that focuses on developing vaccines to address public health threats. They utilize innovative technology platforms to create novel vaccines for a variety of infectious diseases. Their goal is to improve global health by providing safe and effective vaccines to combat emerging pathogens and prevent epidemics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#45 in Uppsala

#812 in Sweden

Uppsala, Sweden

Novavax Ab

Forward Citations = 27

8 inventors:

Bror Morein (7 out of 25 patents)

Karin Lövgren Bengtsson (3 out of 5 patents)

Karin Lovgren Bengtsson (3 out of 6 patents)

4. Albertus D M E Osterhaus (2 out of 3 patents)

5. Karin Lovgren-Bengtsson (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novavax Ab. Retrieved from https://idiyas.com/company/novavax-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]